MX2024003012A - Nuevo polipeptido. - Google Patents
Nuevo polipeptido.Info
- Publication number
- MX2024003012A MX2024003012A MX2024003012A MX2024003012A MX2024003012A MX 2024003012 A MX2024003012 A MX 2024003012A MX 2024003012 A MX2024003012 A MX 2024003012A MX 2024003012 A MX2024003012 A MX 2024003012A MX 2024003012 A MX2024003012 A MX 2024003012A
- Authority
- MX
- Mexico
- Prior art keywords
- treating
- subject
- associated disorders
- preventing
- new polypeptide
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 5
- 206010013774 Dry eye Diseases 0.000 abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3723—Polyamines or polyalkyleneimines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente descripción proporciona un nuevo polipéptido. También se proporciona una composición oftálmica para tratar o prevenir el ojo seco (DE) o trastornos asociados a DE. También se proporciona un método para tratar o prevenir DE o trastornos asociados a DE, estimular las lágrimas, estabilizar la película lagrimal o cualquier combinación de los mismos en un sujeto en necesidad de lo mismo, el cual comprende administrar al sujeto una cantidad efectiva de los nuevos péptidos. También se proporciona un producto para el cuidado de lentes de contacto que comprende los nuevos péptidos y el método de preparación del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021118499 | 2021-09-15 | ||
| PCT/CN2022/119040 WO2023040963A1 (en) | 2021-09-15 | 2022-09-15 | Novel polypeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024003012A true MX2024003012A (es) | 2024-05-02 |
Family
ID=85601897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024003012A MX2024003012A (es) | 2021-09-15 | 2022-09-15 | Nuevo polipeptido. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240360183A1 (es) |
| EP (1) | EP4402156A1 (es) |
| JP (1) | JP2024535846A (es) |
| KR (1) | KR20240102944A (es) |
| CN (1) | CN118510793A (es) |
| AU (1) | AU2022347771A1 (es) |
| CA (1) | CA3231655A1 (es) |
| IL (1) | IL311448A (es) |
| MX (1) | MX2024003012A (es) |
| WO (1) | WO2023040963A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107573412B (zh) * | 2016-07-04 | 2021-04-27 | 上海清流生物医药科技有限公司 | 一种新型天然蛋白及其应用 |
| CN110004105B (zh) * | 2018-01-05 | 2023-09-29 | 上海普佑生物医药有限公司 | 一种蛋白在细胞培养中的应用 |
| CN110302362B (zh) * | 2018-03-20 | 2024-04-05 | 上海普佑生物医药有限公司 | 一种蛋白在制备预防和治疗糖尿病并发症的药物中的应用 |
-
2022
- 2022-09-15 AU AU2022347771A patent/AU2022347771A1/en active Pending
- 2022-09-15 WO PCT/CN2022/119040 patent/WO2023040963A1/en active Application Filing
- 2022-09-15 CA CA3231655A patent/CA3231655A1/en active Pending
- 2022-09-15 JP JP2024516814A patent/JP2024535846A/ja active Pending
- 2022-09-15 EP EP22869331.3A patent/EP4402156A1/en active Pending
- 2022-09-15 IL IL311448A patent/IL311448A/en unknown
- 2022-09-15 MX MX2024003012A patent/MX2024003012A/es unknown
- 2022-09-15 CN CN202280076138.2A patent/CN118510793A/zh active Pending
- 2022-09-15 KR KR1020247012149A patent/KR20240102944A/ko active Pending
-
2024
- 2024-03-14 US US18/605,501 patent/US20240360183A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240360183A1 (en) | 2024-10-31 |
| JP2024535846A (ja) | 2024-10-02 |
| AU2022347771A1 (en) | 2024-03-28 |
| CN118510793A (zh) | 2024-08-16 |
| EP4402156A1 (en) | 2024-07-24 |
| IL311448A (en) | 2024-05-01 |
| WO2023040963A1 (en) | 2023-03-23 |
| KR20240102944A (ko) | 2024-07-03 |
| CA3231655A1 (en) | 2023-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hafezi et al. | Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas | |
| RU2018114926A (ru) | Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения | |
| EP1706094A4 (en) | TREATMENT OF EYE DISEASES | |
| RU2017129247A (ru) | Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний | |
| Wijemanne et al. | Apraclonidine in the treatment of ptosis | |
| Sanchez-Avila et al. | Plasma rich in growth factors for the treatment of dry eye after LASIK surgery | |
| RU2018142149A (ru) | Жидкая композиция нейротоксина, стабилизированная триптофаном или тирозином | |
| EA201891730A1 (ru) | Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности | |
| Konstantopoulos et al. | Corneal stability of LASIK and SMILE when combined with collagen cross-linking | |
| MX2021005077A (es) | Peptidos y composiciones farmaceuticas para tratar enfermedades oculares. | |
| EA201990752A1 (ru) | Офтальмологический состав, содержащий цитиколин, переносимый липосомой, для лечения глаукомы | |
| MX2023009352A (es) | Metodos para la administracion oftalmica de roflumilast. | |
| Moshirfar et al. | Chemical conjunctivitis and diffuse lamellar keratitis after removal of eyelash extensions | |
| MX2024003012A (es) | Nuevo polipeptido. | |
| WO2021030538A3 (en) | Hyaluronidase compositions and methods of using same to treat a cosmetic condition | |
| EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода | |
| WO2019054960A3 (en) | Improving ophthalmic telomerase activity via topical and local ocular applications and preventing, delaying and / or treating impairments or diseases experienced due to degenerative processes (such as aging) | |
| Nayak et al. | Golden ring in the eyes: Weill-Marchesani syndrome | |
| RU2014106328A (ru) | Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки | |
| García-Medina et al. | Focal vitreomacular traction: Resolution after ocular massage | |
| RU2620248C1 (ru) | Способ устранения паралитического лагофтальма | |
| HK1252301A2 (zh) | 一種含有重組人溶菌酶的新型人工淚液 | |
| MX2022011131A (es) | Nuevo uso y metodo de tratamiento. | |
| US11229549B2 (en) | Tear transplantation and multi-part contact lens with absorbent portion | |
| Barberá et al. | Transepithelial phototherapeutic keratectomy to treat chronic laser in situ keratomileusis-flap macrostriae. A case review |